Alternative mechanisms for tiotropium.
暂无分享,去创建一个
E. Bateman | K. Rabe | T. Welte | S. Rennard | B. Rubin | N. Gross | P. Barnes | J. Nadel | P. Dicpinigaitis | R. Gosens | K. Racké | M. Pfeifer | I. Wessler | Tobias Welte | Kurt Racké | Ignaz Wessler | S. Rennard | Eric D. Bateman | Peter J. Barnes | Peter V. Dicpinigaitis | Nicholas J. Gross | Jay A. Nadel | Klaus F. Rabe | Bruce K. Rubin | E. Bateman | Klaus F Rabe | Klaus F. Rabe
[1] P. Barnes,et al. Autonomic Factors in Hyperreactivity of Airway Smooth Muscle , 2011 .
[2] M. Decramer,et al. Effectiveness of Tiotropium as First Maintenance Drug in Patients with COPD. Secondary Analysis of the UPLIFT Trial. , 2009, ATS 2009.
[3] A. Negassa,et al. Effect of Tiotropium on Cough Reflex Sensitivity in Acute Viral Cough , 2008, Lung.
[4] K. Racké,et al. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts , 2008, European Respiratory Journal.
[5] Liam Ck. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008 .
[6] K. Racké,et al. Pulmonary fibroblasts, an emerging target for anti-obstructive drugs , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] T. Welte,et al. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. , 2007, Respiratory medicine.
[8] A. Halayko,et al. Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[9] A. Halayko,et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison , 2007, European Respiratory Journal.
[10] G. Donaldson,et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD , 2007, European Respiratory Journal.
[11] L. Kunz,et al. Ovarian acetylcholine and ovarian KCNQ channels: insights into cellular regulatory systems of steroidogenic granulosa cells. , 2007, Life sciences.
[12] C. Kirkpatrick,et al. Recent progress in understanding the non-neuronal cholinergic system in humans. , 2007, Life sciences.
[13] O. Holz,et al. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. , 2007, Life sciences.
[14] J. Park,et al. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. , 2007, Life sciences.
[15] P. Paré,et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. , 2007, The European respiratory journal.
[16] J. Nadel. Innate immune mucin production via epithelial cell surface signaling: relationship to allergic disease , 2007, Current opinion in allergy and clinical immunology.
[17] M. Pittelkow,et al. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. , 2006, The Journal of investigative dermatology.
[18] K. Racké,et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. , 2006, American journal of respiratory cell and molecular biology.
[19] D. Bolser. Current and future centrally acting antitussives , 2006, Respiratory Physiology & Neurobiology.
[20] J. Wess,et al. Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse , 2006, Respiratory research.
[21] M. Lenburg,et al. Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. , 2006, American journal of respiratory cell and molecular biology.
[22] Jeffrey M Drazen,et al. Chronic effects of mechanical force on airways. , 2006, Annual review of physiology.
[23] V. Brusasco,et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.
[24] L. Boulet,et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. , 2006, Chest.
[25] C. Billington,et al. Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth. , 2005, Biochemistry.
[26] R. Gosens,et al. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. , 2005, American journal of respiratory and critical care medicine.
[27] H. Koepsell,et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.
[28] A. Anzueto,et al. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. , 2005, Pulmonary pharmacology & therapeutics.
[29] J. Nadel,et al. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] K. Belmonte. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[31] A. Fryer,et al. Beta2-agonist and anticholinergic drugs in the treatment of lung disease. , 2005, Proceedings of the American Thoracic Society.
[32] K. Chung. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[33] J. Luketich,et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts , 2004, Respiratory research.
[34] R. Gosens,et al. Acetylcholine: a novel regulator of airway smooth muscle remodelling? , 2004, European journal of pharmacology.
[35] K. Kawashima,et al. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. , 2004, Frontiers in bioscience : a journal and virtual library.
[36] J. Hogg,et al. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.
[37] K. Racké,et al. The airway cholinergic system: physiology and pharmacology. , 2004, Pulmonary pharmacology & therapeutics.
[38] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[39] B. Make,et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.
[40] M. Pfeifer,et al. Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD. , 2004, Chest.
[41] J. Agnew,et al. The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD. , 2004, Chest.
[42] M. Decramer,et al. Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift Trial , 2004, COPD.
[43] M. Acevedo. Effect of acetyl choline on ion transport in sheep tracheal epithelium , 1994, Pflügers Archiv.
[44] Nicholas J Gross,et al. Tiotropium Bromide , 2012 .
[45] S. Sinha,et al. Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease. , 2003, The Indian journal of chest diseases & allied sciences.
[46] R. Pauwels,et al. Chronic obstructive pulmonary disease: molecular and cellularmechanisms , 2003, European Respiratory Journal.
[47] J. McConville,et al. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. , 2003, American journal of respiratory cell and molecular biology.
[48] D. Zoukhri,et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. , 2003, American journal of physiology. Cell physiology.
[49] H. Kilbinger,et al. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. , 2003, Life sciences.
[50] K. Kawashima,et al. Evolutional study on acetylcholine expression. , 2003, Life sciences.
[51] R. Gosens,et al. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. , 2003, American journal of respiratory cell and molecular biology.
[52] V. Brusasco,et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.
[53] P. Barnes,et al. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. , 2002, Drugs of today.
[54] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[55] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[56] J. Vestbo. Epidemiological studies in mucus hypersecretion. , 2002, Novartis Foundation symposium.
[57] J. Wess,et al. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M2- and M4-receptor-deficient mice , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[58] C. Kirkpatrick,et al. The Non-neuronal cholinergic system: an emerging drug target in the airways. , 2001, Pulmonary pharmacology & therapeutics.
[59] H. Kilbinger,et al. Release of non‐neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters , 2001, British journal of pharmacology.
[60] B. Rubin,et al. Regulation of secretion from mucous and serous cells in the excised ferret trachea. , 2001, Respiration physiology.
[61] M. Triggiani,et al. Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors1 , 2001, The Journal of Immunology.
[62] H. Kilbinger,et al. The biological role of non-neuronal acetylcholine in plants and humans. , 2001, Japanese journal of pharmacology.
[63] I. Wessler,et al. Muscarinic control of histamine release from airways. Inhibitory M1-receptors in human bronchi but absence in rat trachea. , 2000, American journal of respiratory and critical care medicine.
[64] P. Jeffery,et al. Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.
[65] A. O. Opazo Saez,et al. Peripheral airway smooth muscle mechanics in obstructive airways disease. , 2000, American journal of respiratory and critical care medicine.
[66] J. Benovic,et al. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. , 2000, American journal of respiratory cell and molecular biology.
[67] Rutgers,et al. Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5′‐monophosphate‐induced bronchoconstriction in patients with COPD , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[68] D. Lauffenburger,et al. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[69] C. Kirkpatrick,et al. THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANS , 1999, Clinical and experimental pharmacology & physiology.
[70] C. Kirkpatrick,et al. Airway epithelium: more than just a barrier! , 1999, Trends in pharmacological sciences.
[71] T. Witek,et al. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.
[72] K. Kubo,et al. Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. , 1998, Journal of applied physiology.
[73] A. Ullrich,et al. Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.
[74] C. Kirkpatrick,et al. Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[75] J. Vestbo,et al. Chronic mucus hypersecretion in COPD and death from pulmonary infection. , 1995, The European respiratory journal.
[76] J. Widdicombe,et al. Neurophysiology of the cough reflex. , 1995, The European respiratory journal.
[77] S. Rennard,et al. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. , 1992, The American journal of physiology.
[78] W. Bailey,et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.
[79] E. Tagaya,et al. Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis. , 1994, Thorax.
[80] R. Lowry,et al. The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. , 1994, British journal of clinical pharmacology.
[81] W. Bennett,et al. The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD. , 1993, Chest.
[82] R. Pierce,et al. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. , 1992, Respiratory medicine.
[83] M. Fujimura,et al. Effects of methacholine induced bronchoconstriction and procaterol induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. , 1992, Thorax.
[84] S. Rennard,et al. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. , 1992, The American journal of physiology.
[85] W. Foster,et al. Influence of inhaled atropine on lung mucociliary function in humans. , 1991, The American review of respiratory disease.
[86] N. Choudry,et al. The effect of altering airway tone on the sensitivity of the cough reflex in normal volunteers. , 1991, The European respiratory journal.
[87] K. Chung,et al. Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. , 1990, Thorax.
[88] N. Gross,et al. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. , 1989, Chest.
[89] P. Barnes,et al. Muscarinic receptor subtypes in human and guinea pig lung. , 1989, European journal of pharmacology.
[90] L. Schwartz,et al. Elevated histamine and tryptase levels in smokers' bronchoalveolar lavage fluid. Do lung mast cells contribute to smokers' emphysema? , 1988, Chest.
[91] R. Lowry,et al. Antitussive properties of inhaled bronchodilators on induced cough. , 1988, Chest.
[92] D. Pavia,et al. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance. , 1986, Thorax.
[93] J. Pounsford,et al. Effect of bronchodilators on the cough response to inhaled citric acid in normal and asthmatic subjects. , 1985, Thorax.
[94] H. Matthys,et al. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis. , 1985, Respiration; international review of thoracic diseases.
[95] N. Sheahan,et al. Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. , 1979, Thorax.
[96] M. Newhouse,et al. Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects. , 1978, Chest.
[97] D. Pavia,et al. Ipratropium bromide: mucociliary clearance rate and airway resistance in normal subjects. , 1977, British journal of diseases of the chest.
[98] P. Annis,et al. Effects of atropine on velocity of tracheal mucus in anesthetized patients. , 1976, Anesthesiology.